Why the new EU packaging rules matter for product quality, patient safety and supply chain management in Life Sciences
17 December 2026 | 11:00 AM CET | Online
Packaging is no longer just a question of protecting a product or reducing its environmental footprint. Under the EU Packaging and Packaging Waste Regulation (PPWR), it is becoming an increasingly important part of the regulatory compliance equation.
For pharmaceutical, biotechnology, medical device and food supplement companies, this raises a critical question: how can packaging meet evolving sustainability requirements without compromising product quality, patient safety or regulatory compliance?
The challenge extends well beyond packaging design. It involves the materials companies select, the information they obtain from suppliers, the documentation they maintain and their ability to anticipate regulatory changes across the product lifecycle.
Beyond Sustainability: A New Set of Compliance Priorities
The PPWR introduces new requirements that will influence how packaging is designed, sourced, qualified and managed.
For the Life Sciences industry, implementation requires particular attention to the relationship between environmental objectives and existing quality and regulatory obligations.
Companies will need to understand which requirements apply to their products, how implementation timelines affect their operations and what actions may be necessary to prepare their packaging and supply chains.
The key challenge is not simply adapting packaging. It is ensuring that every change remains compatible with the quality and compliance expectations of a highly regulated industry.
Article 5: What Do You Really Know About Your Packaging Materials?
One of the areas requiring particular attention is Article 5 of the PPWR, which addresses substances of concern in packaging.
For Life Sciences companies, this brings supplier transparency, material declarations and compliance documentation into sharper focus.
Understanding the composition of packaging materials and obtaining reliable information from suppliers will be important when assessing regulatory requirements and potential compliance risks.
The growing regulatory attention to per- and polyfluoroalkyl substances (PFAS) adds another dimension to these considerations, making it increasingly relevant for companies to assess potential exposure and anticipate future supply chain challenges.
From Regulatory Requirements to Practical Readiness
Understanding the regulation is only the starting point. Companies must also consider how to translate its requirements into practical actions.
Which packaging materials may require further assessment? What information should be requested from suppliers? How can existing qualification and documentation processes support compliance? And how should companies prepare for emerging regulatory expectations?
These are among the questions that will guide our upcoming webinar, “PPWR Essentials: Key Insights for the Life Science Industry.”
ProductLife Group experts will examine the regulatory framework and its practical implications for pharmaceutical, biotechnology, medical device and food supplement companies.
What You Will Learn
During the session, we will explore:
- The key PPWR requirements and their implementation timeline.
- How the regulation applies to different Life Sciences sectors.
- Article 5 and the management of substances of concern in packaging.
- Supplier qualification, material declarations and compliance documentation.
- PFAS-related considerations and emerging regulatory trends.
- Practical actions to support PPWR readiness and long-term compliance.
Prepare Your Packaging Strategy for Evolving EU Requirements
As packaging requirements evolve, Life Sciences companies need to consider regulatory compliance, product quality, patient safety and supplier management together.
Who will be speaking
Speakers: Daniele Calzolari
Moderator: Silvio Mastrominico
Date and time: 17 December 2026 | 11:00 AM CET
Register for free